A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot, which was created for the...Read More
RIBOMIC Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies called the RiboART System. RIBOMIC has been promoting the pharmaceutical discovery program in collaboration...Read More
Aptamer Solutions Ltd: Continued success and growth has enabled Aptamer Group to restructure its Scientific Operations team. Increasing interest in the development of aptamers against small molecule targets has led to the formation of a dedicated scientific team. This is...Read More
PROTOCOL/METHOD ISSN: 2514-3247 Aptamers (2018), Vol 2, in press Published online: 12 June 2018 Full Text Access Sladjana Slavkovic and Philip E. Johnson* Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario, Canada, M2R 1A1 *Correspondence...Read More
We are delighted to announce that Professor Günter Mayer will chair Aptamers 2019. Professor Mayer is the Professor of Chemical Biology at Life and Medical Sciences Institute (LIMES), Bonn University, Germany, and heads an international team of researchers investigating the use of...Read More
Fee Structure Early bird and group discounts are available. Register 3 for the price of 2 until 31 December 2018 (cheapest registration free – Promocode: 3for2)* Register 4 for the price of 3 any time (cheapest registration free – Promocode:...Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
